NCT00956397View on ClinicalTrials.gov

Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2012

Conditions
Functional DyspepsiaSmall Intestinal Bacterial OvergrowthChronic Abdominal Discomfort
Interventions
DRUG

Rifaximin

rifaximin 550 mg TID PO x 10 days

PROCEDURE

Lactulose Breath Test

Test will begin with a baseline breath sample followed by ingestion of 10g of lactulose (Xactdose, South Beloit, IL) in 100ml of water. Breath samples will be collected every 15 min for 180 min. Gas samples will be analyzed for hydrogen and methane using a gas chromatograph (Model SC, Quintron Instruments, Milwaukee, WI).

DRUG

Placebo

placebo TID x 10 days

Trial Locations (1)

87131

General Clinical Research Center, Albuquerque

All Listed Sponsors
lead

Henry C. Lin, MD

FED

NCT00956397 - Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia | Biotech Hunter | Biotech Hunter